A viral health claim often circulates with the headline “Canadian researchers discover new evidence that vitamin D shuts down cancer cells.”
This refers to research from McGill University in Canada, led by professors John White and David Goltzman, published around 2012–2013 (and popularized in articles like one from Daily Health Post in 2013).
Key Findings from the McGill Study
- The active form of vitamin D (calcitriol or 1,25-dihydroxyvitamin D) inhibits the protein cMYC, a key driver of uncontrolled cell division elevated in over half of cancers.
- Vitamin D reduces cMYC production, accelerates its degradation, and boosts a natural antagonist (MXD1), effectively “shutting down” cMYC function.
- In mouse models, topical or systemic vitamin D lowered cMYC levels in skin and colon tissues.
- Mice lacking the vitamin D receptor had elevated cMYC, supporting its protective role.
This provides a molecular mechanism for vitamin D’s potential anti-cancer effects, building on lab evidence that it promotes cell differentiation, induces apoptosis (cell death), and curbs proliferation.
Is This “New” Evidence?
- The core discovery is over a decade old—no major recent (2024–2025) breakthrough from Canadian researchers matches the exact phrasing.
- Vitamin D’s anti-cancer potential in lab studies (inhibiting growth, angiogenesis, metastasis) is well-established but not new.
Broader Evidence on Vitamin D and Cancer
Lab/animal studies consistently show benefits:
- Reduces tumor growth and promotes cancer cell death.
- Epidemiological data links higher vitamin D levels/sun exposure to lower risk of cancers (e.g., colorectal, breast).
However, large human trials (e.g., VITAL trial, NCI reviews) show:
- Supplements do not reliably prevent cancer incidence.
- Possible modest reduction in cancer mortality (e.g., 6–16% in some meta-analyses), especially in deficient individuals.
- No strong evidence vitamin D “shuts down” cancer in people—benefits are preventive/supportive, not curative.
Recommendations
Vitamin D is crucial for bone health, immunity, and possibly reducing some cancer risks—aim for blood levels of 30–50 ng/mL via sun, food (fatty fish, fortified dairy), or supplements (consult a doctor, as excess can cause issues like hypercalcemia).
The McGill work is legitimate science highlighting a mechanism, but headlines exaggerate it as a breakthrough “cure.” Always verify with recent, peer-reviewed sources—vitamin D supports health but isn’t a standalone cancer treatment. If concerned about cancer risk, talk to a healthcare provider!